Pathophysiology and Prognosis in Vietnamese Adults with Tuberculous Meningitis

Journal of Infectious Diseases

Volumn 188, Issue 8, 2003, Pages 1105-1115

  Thwaites, Guy E ^a,c   Simmons, Cameron P ^a,c   Quyen, Nguyen Than Ha ^b   Chau, Tran Thi Hong ^b   Mai, Pham Phuong ^b   Dung, Nguyen Thi ^b   Phu, Nguyen Hoan ^b   White, Nicholas P ^a,c   Hien, Tran Tinh ^b   Farrar, Jeremy J ^a,c  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GAMMA INTERFERON; GELATINASE B; GLUCOSE; IMMUNOGLOBULIN G; INTERLEUKIN 8; ISONIAZID; LACTIC ACID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GLUCOSE BRAIN LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LACTIC ACIDOSIS; LEUKOCYTE COUNT; MEMBRANE PERMEABILITY; MORTALITY; NEUTROPHIL; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; TUBERCULOUS MENINGITIS; VIET NAM;

EID: 0242333163     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/378642     Document Type: Article

References (31)

1. Hosoglu S, Geyik MF, Balik I, et al. Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 2002; 6:64-70.
2. Prasad K, Volmink J, Menon GR. Steroids for treating tuberculous meningitis. Cochrane Database Syst Rev 2000; 3:CD00224
3. Tsenova L, Bergtold A, Freedman VH, Young RA, Kaplan G. Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci USA 1999; 96:5657-62.
4. Tsenova L, Sokol K, Freedman VH, Kaplan G. A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death. J Infect Dis 1998; 177:1563-72.
5. Akalin H, Akdis AC, Mistik R, Helvaci S, Kilicturgay K. Cerebrospinal fluid interleukin-beta/interleukin-1 receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis. Scand J Infect Dis 1994; 26:667-74.
6. Glimaker M, Kragsbjerg P, Forsgren M, Olcen P, Tumor necrosis factor-alpha (TNF alpha) in cerebrospinal fluid from patients with meningitis of different etiologies: high levels of TNF alpha indicate bacterial meningitis. J Infect Dis 1993; 167:882-9.
7. Rydberg J, Miorner H, Chandramuki A, Lantz M. Assessment of a possible imbalance between tumor necrosis factor (TNF) and soluble TNF receptor forms in tuberculous infection of the central nervous system. J Infect Dis 1995; 172:301-4.
8. Donald PR, Schoeman JF, Beyers N, et al. Concentrations of Interferon gamma, tumor necrosis factor alpha, and interleukin-1 beta in the cerebrospinal fluid of children treated for tuberculous meningitis. Clin Infect Dis 1995; 21:924-9.
9. Mastroianni CM, Paoletti F, Lichtner M, D'Agostino C, Vullo V, Delia S. Cerebrospinal fluid cytokines in patients with tuberculous meningitis. Clin Immunol Immunopathol 1997; 84:171-6.
10. Brown HC, Chau TT, Mai NT, et al. Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology 2000; 55: 104-11.
11. Matsuura E, Umehara F, Hashiguchi T, Fujimoto N, Okada Y, Osame M. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis. J Neurol Sci 2000; 173:45-52.
12. Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996; 156:1-4.
13. Price NM, Farrar J, Tran TT, Nguyen TH, Tran TH, Friedland JS. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo. J Immunol 2001; 166:4223-30.
14. Medical Research Council. Streptomycin treatment of tuberculous meningitis. BMJ 1948; 1:582-597.
15. Fishman R. Cerebrospinal fluid in diseases of the nervous system. 2d ed. Philadelphia: W.B. Saunders, 1992:183-252.
16. Girgis NI, Sultan Y, Farid Z, et al. Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg 1998; 58:28-34.
17. Thwaites GE, Chau TT, Caws M, et al. Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis. Int J Tuberc Lung Dis 2002; 6:865-71.
18. Schoeman JF, Elshof JW, Laubscher JA, Janse van Rensburg A, Donald PR. The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis. Ann Trop Paediatr 2001; 21:299-305.
19. Lepper MH, Spies HW. The present status of the treatment of tuberculosis of the central nervous system. Ann N Y Acad Med 1963; 106: 106-123.
20. Zhang Y, Broser M, Cohen H, et al. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest 1995; 95:586-92.
21. Juffermans NP, Verbon A, van Deventer SJ, et al. Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect Immun 1999; 67: 4295-7.
22. Kurashima K, Mukaida N, Fujimura M, et al. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med 1997; 155:1474-7.
23. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19:93-129.
24. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995; 63:3231-4.
25. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992; 175:323-9.
26. Tauber MG, Khayam-Bashi H, Sande MA. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis 1985; 151:528-34.
27. Thwaites GE, Chau TT, Mai NT, Drobniewski F, McAdam K, Farrar J. Tuberculous meningitis. J Neurol Neurosurg Psychiatry 2000; 68:289-99.
28. Dastur DK, Manghani DK, Udani PM. Pathology and pathogenetic mechanisms in neurotuberculosis. Radiol Clin North Am 1995; 33:733-52.
29. Karstaedt AS, Valtchanova S, Barriere R, Crewe-Brown HH. Tuberculous meningitis in South African urban adults. Q J Med 1998; 91:743-7.
30. Pedrosa J, Saunders BM, Appelberg R, Orme IM, Silva MT, Cooper AM. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun 2000; 68:577-83.
31. Dieli F, Sireci G, Di Sano C, Champagne E, Fournie JJ, Salerno JI. Predominance of Vgamma9/Vdelta2 T lymphocytes in the cerebrospinal fluid of children with tuberculous meningitis: reversal after chemotherapy. Mol Med 1999; 5:301-12.